Article Information
History
- August 25, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Vatsalya Vatsalya, MD, MS, PgD, MSc1,2,*,
- Fengyuan Li, PhD1,3,
- Jane Frimodig, PhD1,2,
- Khushboo S. Gala, MD1,
- Shweta Srivastava, PhD1,4,
- Maiying Kong, PhD2,5,
- Vijay A Ramchandani, PhD6,
- Wenke Feng, PhD1,3,7,10,
- Xiang Zhang, PhD3,7,8,9,10 and
- Craig J McClain, MD1,2,3,7,10
- 1Department of Medicine, University of Louisville, Louisville, KY USA
- 2Robley Rex VA Medical Center, Louisville, KY USA
- 3University of Louisville Alcohol Research Center, Louisville, KY USA
- 4Envirome Institute, University of Louisville, Louisville, KY USA
- 5Department of Bioinformatics and Biostatistics, University of Louisville, Louisville, KY USA
- 6National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD USA
- 7Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY USA
- 8Department of Chemistry, University of Louisville, Louisville, KY USA
- 9Center for Regulatory and Environmental Analytical Metabolomics, University of Louisville, Louisville, KY USA
- 10University of Louisville Hepatobiology & Toxicology COBRE, Louisville, KY USA
- ↵*Corresponding Author:
Vatsalya Vatsalya, MD, MS, PgD, MSc, Department of Medicine, University of Louisville School of Medicine, 505 S. Hancock St., CTR Room 514A, Louisville KY 40202, Landline: 502-852-8928, Fax: 502-852-8927, Cell: 502-488-0446; Email: v0vats01{at}louisville.edu
Author contribution: VV is the project PI and designed the study. VV and JF participated in the clinical sampling and clinical data analyses. FL performed in vitro, and JF performed plasma testing. FL, JF, and VV participated in the overall laboratory analyses. MK and VV developed the dosing range. VV, CJM and VAR developed the pharmacokinetic profile. VV, FL, SS, and JF interpreted the results. VV, FL, JF, SS, and KSG wrote the manuscript. CJM, MK, WF, XZ, and VAR critically reviewed the manuscript and contributed scientifically. All authors have approved the submission version of this manuscript.
Posted August 25, 2020.
Therapeutic Prospects for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-vitro Evidence and Pharmacokinetic Profile
